MedStar Georgetown University-Lombardi CCC — Washington D.C., District of Columbia

MedStar Georgetown University-Lombardi CCC is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

MedStar Georgetown University-Lombardi CCC has participated in 1 clinical trials.

Therapeutic areas: Metastatic Breast Cancer, Leptomeningeal Disease.

Sponsors: University of Alabama at Birmingham.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MedStar Georgetown University-Lombardi CCC?

MedStar Georgetown University-Lombardi CCC has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MedStar Georgetown University-Lombardi CCC conducted?

MedStar Georgetown University-Lombardi CCC has 1 clinical trials on record. Their work covers Metastatic Breast Cancer, Leptomeningeal Disease.

Is MedStar Georgetown University-Lombardi CCC accredited by Crixeo Health?

MedStar Georgetown University-Lombardi CCC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MedStar Georgetown University-Lombardi CCC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.